Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BLLN
BLLN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BLLN News
Unity Confirm Launches Non-Invasive Prenatal Testing Breakthrough
May 01 2026
PRnewswire
Jim Cramer's Insights on Various Stocks
Apr 28 2026
CNBC
Jim Cramer's Insights on Various Stocks
Apr 25 2026
CNBC
BillionToOne Appoints VP of Medical Affairs for Oncology
Apr 02 2026
PRnewswire
Wall Street Analysts Adjust Ratings
Mar 05 2026
Benzinga
BillionToOne Reports 113% Revenue Growth and Raises 2026 Guidance
Mar 05 2026
NASDAQ.COM
BillionToOne Reports Strong Q4 and 2025 Financial Results
Mar 04 2026
seekingalpha
Napean Trading Acquires Stake in BillionToOne
Feb 14 2026
Fool
BillionToOne Launches New Liquid Biopsy Applications for Enhanced Cancer Treatment Insights
Feb 10 2026
Newsfilter
BillionToOne Expands Leadership in HDFN and FNAIT Testing
Feb 09 2026
PRnewswire
BillionToOne Expands Leadership in HDFN and Launches FNAIT Testing
Feb 09 2026
Newsfilter
2025 IPO Class: 3 Stocks Showing Positive Chart Trends
Jan 23 2026
Barron's
BillionToOne Reiterates FY2025 Guidance, Projects 40% Growth for FY2026
Jan 13 2026
Benzinga
BillionToOne (BLLN) Reaffirms 2025 Revenue Outlook of $293M to $299M
Jan 12 2026
NASDAQ.COM
BillionToOne Selected as Liquid Biopsy Platform for Japan's LC-SCRUM-TRY Study
Jan 06 2026
PRnewswire
BillionToOne Selects Northstar Select as Liquid Biopsy Platform for Japan's LC-SCRUM-TRY Study
Jan 06 2026
Newsfilter
Show More News
